Literature DB >> 225521

Herpes simplex virus type 1 infection of isogenic Epstein-Barr virus genome-negative and -positive Burkitt's lymphoma-derived cell lines.

S S Leinbach, W C Summers.   

Abstract

The Epstein-Barr virus (EBV) genome-negative Burkitt's lymphoma-derived cell lines BJAB and Ramos and their in vitro EBV-converted sublines BJAB-B1, BJAB-A5, BJAB-B95-8, and AW-Ramos were infected with high multiplicities of herpes simplex virus type 1 (HSV-1; 10 to 70 PFU/cell). Cultures were monitored for cell growth and HSV-1 DNA synthesis. EBV-converted BJAB cultures were more permissive for HSV-1 infection than BJAB cultures. Significant cell killing and HSV-1 DNA synthesis were observed during the first 48 h of infection in the EBV-converted BJAB cultures but not in the BJAB cultures. The EBV-converted BJAB-B1 cell line contains an appreciable fraction of EBV-negative cells. Therefore, it was cloned. EBV-positive and -negative cells were identified by using EBV-determined nuclear antigen anti-complement immunofluorescence. Two types of subclones were identified: (i) those which contained both EBV-determined nuclear antigen-positive and -negative cells and (ii) those which contained only EBV-determined nuclear antigen-negative cells. When levels of HSV-1 DNA synthesis were measured in these subclones, it was found that the former were more permissive for HSV-1 infection than the latter. Thus, the presence of the EBV genome in BJAB cells correlates with increased permissiveness of these cells for HSV-1 during the first 48 h of infection. Nonetheless, persistent HSV-1 infections were established in both BJAB and EBV-converted BJAB-B1 cultures. No differences in extent of permissiveness for HSV-1 infection were found for Ramos and EBV-converted AW-Ramos cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225521      PMCID: PMC353319     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Differences in the ConA-induced redistribution and agglutination patterns of EBV genome-free and EBV-carrying human lymphoma lines.

Authors:  E Yefenof; G Klein; H Ben-Bassat; L Lundin
Journal:  Exp Cell Res       Date:  1977-08       Impact factor: 3.905

2.  Heterogeneity of Epstein-Barr virus originating from P3HR-1 cells. I. Studies on EBNA induction.

Authors:  K O Fresen; B Merkt; G W Bornkamm; H Hausen
Journal:  Int J Cancer       Date:  1977-03-15       Impact factor: 7.396

3.  Heterogeneity of Epstein-Barr virus. II. Induction of early antigens (EA) by complementation.

Authors:  H zur Hausen; K O Fresen
Journal:  Virology       Date:  1977-08       Impact factor: 3.616

4.  Replication of cytomegalovirus DNA in human lymphoblastoid cells.

Authors:  E S Huang; J S Pagano
Journal:  IARC Sci Publ       Date:  1975

5.  Surface glycoprotein patterns of normal and malignant human lymphoid cells. II. B cells, B blasts and Epstein-Barr virus (EBV)-positive and -negative B lymphoid cell lines.

Authors:  K Nilsson; L C Andersson; C G Gahmberg; H Wigzell
Journal:  Int J Cancer       Date:  1977-11-15       Impact factor: 7.396

6.  Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells.

Authors:  I McConnell; G Klein; T F Lint; P J Lachmann
Journal:  Eur J Immunol       Date:  1978-07       Impact factor: 5.532

7.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

8.  Cell-free synthesis of herpes simplex virus proteins.

Authors:  K J Cremer; W C Summers; R F Gesteland
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

9.  Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.

Authors:  G Klein; T Lindahl; M Jondal; W Leibold; J Menézes; K Nilsson; C Sundström
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

10.  Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines.

Authors:  G Klein; J Zeuthen; P Terasaki; R Billing; R Honig; M Jondal; A Westman; G Clements
Journal:  Int J Cancer       Date:  1976-11-15       Impact factor: 7.396

View more
  11 in total

1.  Characterization of herpes simplex virus persistence in a human T lymphoblastoid cell line.

Authors:  P J Cummings; R J Lakomy; C R Rinaldo
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

2.  Expression of the HSV specified major DNA-binding protein in virus infected RAJI and VERO cells.

Authors:  M Lehtinen; P Kulomaa; T Lehtinen
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Amplification and deregulation of MYC following Epstein-Barr virus infection of a human B-cell line.

Authors:  J Lacy; W P Summers; M Watson; P M Glazer; W C Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  HSV infected RAJI-cells specify HSV specific immediate early and/or early DNA-binding proteins.

Authors:  M Lehtinen
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

5.  An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators.

Authors:  M A Cox; J Leahy; J M Hardwick
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

6.  Regulation of persistent infection with herpes simplex virus in vitro by hydrocortisone.

Authors:  Y Nishiyama; F Rapp
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

7.  Herpesvirus-lymphoid cell interactions: comparative studies on the biology of herpes simplex virus-induced Fc receptors in B, T, and "null" lymphoid cell lines.

Authors:  J Menezes; A E Bourkas
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

8.  Herpes simplex virus type 1 long-term persistence, latency, and reactivation in infected Burkitt lymphoma cells.

Authors:  W Hampl; S Conrad; A K Kleinschmidt
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

9.  Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alpha.

Authors:  J Gosselin; L Flamand; M D'Addario; J Hiscott; J Menezes
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

10.  Post-transcriptional mechanisms of deregulation of MYC following conversion of a human B cell line by Epstein-Barr virus.

Authors:  J Lacy; W P Summers; W C Summers
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.